VEGFR2/CD309 antibody (AA 1153-1182)
Quick Overview for VEGFR2/CD309 antibody (AA 1153-1182) (ABIN3031548)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1153-1182
-
Purpose
- KDR Antibody / Kinase Insert Domain Receptor / VEGFR2
-
Purification
- Antigen affinity
-
Immunogen
- A portion of amino acids 1153-1182 from the human protein was used as the immunogen for this KDR antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the KDR antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the KDR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- KDR
-
Background
- KDR is a major growth factor for endothelial cells. This protein encodes one of the two receptors of the KDR. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc..
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-